Deep Medicine Acquisition Corp.
DMAQ · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $4,106 | $4,311 | $5,389 | $21,859 |
| % Growth | -4.8% | -20% | -75.3% | – |
| Cost of Goods Sold | $1,259 | $2,399 | $1,726 | $7,242 |
| Gross Profit | $2,847 | $1,912 | $3,663 | $14,617 |
| % Margin | 69.3% | 44.4% | 68% | 66.9% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $1,024 |
| SG&A Expenses | $3,340 | $2,637 | $2,725 | $5,645 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $4,621 |
| Other Operating Expenses | $0 | $0 | $446 | $2,655 |
| Operating Expenses | $3,340 | $2,637 | $3,171 | $8,300 |
| Operating Income | -$1,113 | -$1,870 | -$1,234 | -$1,211 |
| % Margin | -27.1% | -43.4% | -22.9% | -5.5% |
| Other Income/Exp. Net | -$6,165 | -$4,773 | -$1,436 | -$6,692 |
| Pre-Tax Income | -$7,278 | -$6,643 | -$2,670 | -$7,904 |
| Tax Expense | $0 | -$3,321 | $0 | -$111 |
| Net Income | -$7,278 | -$3,321 | -$2,670 | -$7,904 |
| % Margin | -177.3% | -77% | -49.5% | -36.2% |
| EPS | -4.87 | -19.69 | -0.094 | -679.35 |
| % Growth | 75.3% | -20,891.5% | 100% | – |
| EPS Diluted | -4.87 | -19.69 | -0.23 | -0.68 |
| Weighted Avg Shares Out | 1,495 | 718 | 11,635 | 11,635 |
| Weighted Avg Shares Out Dil | 1,495 | 718 | 11,635 | 11,635 |
| Supplemental Information | – | – | – | – |
| Interest Income | $79 | $65 | $55 | $16 |
| Interest Expense | -$108 | -$1,517 | $1,491 | -$6,933 |
| Depreciation & Amortization | $0 | $0 | $0 | $351 |
| EBITDA | -$1,113 | -$1,870 | -$1,234 | -$14,595 |
| % Margin | -27.1% | -43.4% | -22.9% | -66.8% |